Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)
Our study showed both in vivo and in vitro that GSH can nearly completely inhibit PSC activation and pancreatic fibrosis induced by high glucose
Because it targets both pathways, many people and clinical trials have shown better average weight loss and robust blood sugar reductions compared with single-target drugs
Why protein matters so much on a GLP-1 GLP-1 medications work by slowing digestion and reducing appetite, which can make it genuinely difficult to hit daily nutrition targets
Core Breakthrough Strategies for Peptide Products 1
Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F